
The flaw in Wes Streeting's AI NHS app plan
Speaking at Blackpool Football Club earlier this week, Wes Streeting announced his latest bid to modernise the NHS: bold new additions to the NHS app. Artificial intelligence would be used to empower people, turning them into experts on their own conditions, while another feature would 'show patients everything from their nearest pharmacy to the best hospital for heart surgery across the country, with patients able to choose based on their preference'. These features will reportedly be introduced within the next three years, with an extra £10 billion allocated by Rachel Reeves in her spending review to fund NHS technology.
How exactly will NHS providers be 'inspired' by patients being offered choice?
Given the impressive capabilities of freely available AI tools, the need to spend £10 billion on bespoke NHS software appears questionable from the outset. Streeting's optimism about the NHS's skill with large IT projects is impressive. I have the NHS app on my phone, and it reliably opens without crashing. With a finger I can ask it to arrange repeat prescriptions or to show me my GP records, although in both cases it responds by saying it can't help as it can't connect to my surgery. The app also offers to transfer me seamlessly to 111 for medical advice where, after only five or six pages of warnings, it asks permission for it to pass on my medical history. With that granted, it passes me to 111 which, having received all my information, starts by asking me my sex at birth.
£10 billion, coincidentally, is the amount the Public Accounts Committee said, in 2013, had been wasted on an abandoned attempt to introduce an electronic patient record system to the NHS. 'The biggest IT failure ever seen', Dan Poulter, back then a Conservative health minister, condemned Labour's incompetence and responded with 'a £1 billion technology fund to help the NHS go paperless by 2018'.
Perhaps readers will be unsurprised to hear that the NHS is not, in fact, now paperless. Or to hear that we're already using artificial intelligence without the government's help. Some colleagues are shy about their use of ChatGPT for clinical knowledge but it's widespread and so it should be. Medical knowledge expanded beyond the bounds of a single person's memory generations ago, and knowing the best ways to look things up has been a key skill ever since.
For patients, ChatGPT, Gemini, Grok, and others already help. I used to sometimes advise people not to look certain matters up, confident that a quick Google would yield them the wrong end of a needlessly frightening stick. Today's large language models are better. For all their hazards, they respond to clinical questions not only with a decent chance of accuracy, but also with a high degree of useful context. They are the best products of some of the world's finest – and most highly paid – minds. Our NHS IT experts may well be poised to do a better job, but history suggests they are more likely to take ChatGPT and ineptly make it worse, wasting another £10 billion in the process.
Notably, Streeting's Blackpool speech was not chiefly about technology. He introduced the NHS App's new features as methods for tackling his real focus of inequality. Beveridge, in 1942, spoke of the need for a welfare state to fight the five giants of idleness, ignorance, disease, squalor and want. Streeting attributed today's inequality to 'poverty, a lack of good work, damp housing, dirty air, and the sporting, travel and cultural opportunities which are afforded to the privileged few being denied to the many'.
The shift worth noticing, because it is society's and not just Streeting's, is that people, and particularly the less fortunate, have ceased being spoken of as though they possess responsibility or control. Both, instead, rest wholly with the state. Streeting is right to care most for the least fortunate, whose opportunities are most constrained, but encouraging them to believe that what freedom they do possess is an illusion, and that they are not active agents but helpless victims, is harmful. Compassion, when sufficiently misguided, can be unkind.
When it comes to My Choice, the app's feature to 'democratise' the NHS, Streeting's thinking seems equally flawed. 'If NHS providers know that their waiting times, health outcomes of their patients and patient satisfaction ratings will all be publicly available,' he said in his speech. 'They will be inspired to respond to patient choice, raise their game and deliver services that patients value.'
This sounds attractive, just as it does to hold the state responsible for everything that's wrong in the world, but it makes as little sense. How exactly will NHS providers be 'inspired' by patients being offered choice? Here in the NHS almost everyone has a job for life, and equality means that within each field we are paid the same, regardless of talent or industry. And the senior managers, the only ones whose jobs are tenuous, almost invariably seem to fail upwards, leaving one post where they've been harmful in order to take another at a higher rate. Odd, to invoke the invisible hand of market forces in a context that effectively bans them.
Streeting appears to be a bright & decent man genuinely trying to improve the NHS. Against an admittedly dire collection of colleagues, he seems to be the highlight of Labour's benches. It is hard not to root for him, especially as any success he has will be our success too. Harder still, sadly, to see him pulling it off.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Guardian
29 minutes ago
- The Guardian
Smoking, drinking too much and being overweight ‘puts one in 50 adults in England at risk of early death'
One in 50 people aged 16 or older in England is at risk of an early death because they smoke, drink too much and are overweight, research has found. This 'triple threat' increases the risk of diseases such as cancer and diabetes and in some cases dying as much as 20 years earlier than they should, a senior doctor has said. About 1 million people in England are living with that threat, an analysis of the Health Survey for England by the charity Action on Smoking and Health (Ash) revealed. They are the 2.2% of the population who use tobacco, drink more than 14 units of alcohol a week and are overweight or obese, as judged by having a body mass index (BMI) of 25 or more. However, 10 million – 22% of the population – exhibit two of the three risky behaviours, Ash found, while 33.9 million (73.6%) have at least one risk factor. Prof Sir Ian Gilmore, the chair of the Alcohol Health Alliance, said: 'It is staggering that as many as one in 50 adults in England are at a much higher risk of dying because of the combination of tobacco, alcohol and unhealthy food. 'Smoking, alcohol and excess weight each significantly increase the risk of serious health problems like cancer, heart disease and liver disease. When these risk factors are combined, the danger to people's health is even greater, leading to higher chances of early death and more years in poor health. 'Together they create a toxic combination that can lead to long-term disability and early death.' A lifelong smoking habit reduces someone's life expectancy by about 10 years and grade three obesity – being severely obese with a BMI of more than 40 – does so by a similar amount. The UK's four chief medical officers recommend that no one drinks more than 14 units of alcohol a week. Gilmore, a former president of the Royal College of Physicians, added: 'Although the risks of two or more risk factors are not purely additive, it is likely that smoking, grade three obesity and heavy drinking will reduce life expectancy by at least 20 years.' Ash also found that: 12.7% of people in England (5.9 million) are overweight and drink more than 14 units but do not smoke. 5.5% (2.5 million) are overweight and smoke but drink less than 14 units. 1.4% (600,000) smoke and drink more than 14 units but have a normal weight. Caroline Cerny, the deputy chief executive of Ash, said: 'The findings are extremely worrying. They provide an insight into the challenges facing the NHS both now and in the future.' The burden of illness in England is rising due to the ageing and growing population and impact of lifestyle-related conditions linked to smoking, drinking and poor diet. Research by the Health Foundation has found that 9 million more people will be living with conditions such as cancer, diabetes, dementia, kidney disease and depression by 2040. Cerny urged Wes Streeting, the health secretary, to include robust measures to improve public health in the government's forthcoming 10-year plan for the NHS. They should include targets to cut smoking, alcohol consumption and overweight, introducing minimum unit pricing of alcohol in England and extending the sugar tax to other unhealthy foods, she said. The Department of Health and Social Care did not comment directly on the findings. A spokesperson said the 10-year health plan, due next Thursday, would shift the NHS from treatment to prevention. Ministers are committed to tackling obesity through a ban on the advertising of junk food on TV before 9pm and a planned new food strategy, they said. They also cited the Tobacco and Vapes Bill, an increase in the public health grant and an extra £310m for treatment of drug and alcohol addiction as evidence of the government's action on public health.

Leader Live
30 minutes ago
- Leader Live
Government climbdown on welfare Bill marks third U-turn this month
Here, the PA news agency looks at three major policy changes this month. – Welfare reforms The Universal Credit and Personal Independence Payment Bill was put in motion to change who could qualify for certain disability and sickness benefits. The package restricted eligibility for Pip, the main disability payment in England, and cut the health-related element of Universal Credit, in a bid to save £5 billion a year by 2030. But a backbench rebellion of more than 120 Labour MPs forced Sir Keir into a U-turn. In an attempt to appease those MPs, planned cuts will now only affect future applications for benefits, rather than existing claimants. – Winter fuel payment The Government scrapped winter fuel payments for pensioners who do not receive pension credits or other means-tested benefits just weeks after it came to power in July. It was described as a 'necessary and responsible' move by Chancellor Rachel Reeves, who argued it would help fill the £22 billion fiscal black hole. The Government said that changing the threshold for the payment would save £1.5 billion each year. But at the start of this month, the Prime Minister announced that the Government would reinstate winter fuel payments for millions of pensioners. The payment, worth up to £300, will be restored to the vast majority of pensioners who previously received it because anyone with an income of under £35,000 a year will now get the payment automatically. The Government said the change will cost £1.25 billion. – Grooming gangs Sir Keir has also U-turned on holding a national inquiry into grooming gangs. In January, the Prime Minister accused those calling for an inquiry of 'jumping on a far-right bandwagon' after tech entrepreneur Elon Musk criticised the UK for its lack of action on the issue. But following the recommendations of a report by Baroness Louise Casey into the scale of group-based child sexual abuse, Sir Keir announced in June that there would be a full national statutory inquiry. The Prime Minister had initially only promised five local inquiries in the most prevalent areas for grooming gangs. Asked about the change, Sir Keir said: 'I've never said we should not look again at any issue.'


Scottish Sun
34 minutes ago
- Scottish Sun
I've gone from a size 20 to an 8 & lost 8 stone on Mounjaro – I've had hair loss but don't mind, I like my locks thinner
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A WOMAN has revealed that thanks to Mounjaro, she has lost eight stone and has dropped from a size 20 to an 8. But Alexandra, 33, who is from the UK and is currently living in Dubai, expressed that since using weight-loss jabs, she has suffered with hair loss. 3 A young woman has revealed that she has slimmed down from a size 20 to an 8 thanks to Mounjaro Credit: tiktok/@alexandraindubai 3 But although Alexandra loves her new frame, she has also suffered with hair loss Credit: tiktok/@alexandraindubai 3 Mounjaro is used to treat type 2 diabetes and obesity Credit: Getty However, the content creator isn't bothered by this, as she claimed she likes her locks thinner. Posting on social media, the brunette beauty, who previously revealed the very scary impact stopping Mounjaro had on her body, shared a before and after look at how her figure has changed since using the fat jabs. In just 12 months, Alexandra confirmed that she lost eight stone, as she wrote: 'What a journey the last year has been. 8 stone lost.' Alexandra confirmed that during April 2024 to April 2025, she was able to totally transform her life, as she recognised: 'Fat and miserable in the UK to living my best life in Dubai. 'I never would have dreamed life could be this good.' When asked if she experienced hair loss, the young woman confirmed: 'I did at month four, horrible but no issues now and I like my hair a bit thinner.' Mounjaro, which is known as the King Kong of jabs, is now being prescribed on the NHS in the first anti-obesity rollout of its kind. It is said to suppress the appetite, making people feel fuller for longer. Such injections are licensed for patients with type 2 diabetes and to assist those who are clinically obese - with a Body Mass Index of 30 or over. One jab is administered each week but the duration is dependent on a person's weight. Sun Health Explainer: Fat jabs The drugs can be lawfully supplied only when prescribed by a practitioner - like a doctor, nurse or a pharmacist-independent prescriber. But many are buying them through online pharmacies with insufficient checks. Best thing I've ever done! Alexandra And just earlier this month, a fat jab warning was issued after more than 100 UK deaths were linked to weight loss drugs. Not only this, but the family of a man from Burton upon Trent, Staffs, who died after taking Mounjaro, are now calling for a probe into the jab's "potential to kill". Social media users react Alexandra's TikTok clip, which was posted under the username @alexandraindubai, has clearly left many open-mouthed, as it has quickly racked up 67,500 views, 3,617 likes and 70 comments. Social media users were stunned by Alexandra's new figure and many raced to the comments to express this. One person said: 'You look amazing.' Another added: 'Wow! That's incredible! Well done you!' Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. A third commented: 'Amazing! You must feel brilliant.' In response, Alexandra wrote back and shared: 'I feel much better that's for sure!! Thank you!' Meanwhile, someone else questioned: 'Is it worth it?' To this, Alexandra confirmed: 'Best thing I've ever done!' The reality of Mounjaro But despite Alexandra's weight loss success, last year it was revealed that Scots nurse Susan McGowan, 58, died after taking low-dose injections of Mounjaro over a fortnight. A probe also found that nearly 400 people have gone to hospital after taking weight loss drugs. Whilst Alexandra dealt with hair loss, the common side effects include nausea, vomiting and diarrhoea, which can lead to severe dehydration. What are the other side effects of weight loss jabs? Like any medication, weight loss jabs can have side effects. Common side effects of injections such as Ozempic include: Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts. Vomiting: Can occur, often in conjunction with nausea. Diarrhea: Some people experience gastrointestinal upset. Constipation: Some individuals may also experience constipation. Stomach pain or discomfort: Some people may experience abdominal pain or discomfort. Reduced appetite: This is often a desired effect for people using Ozempic for weight loss. Indigestion: Can cause a feeling of bloating or discomfort after eating. Serious side effects can also include: Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting. Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon. Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic. Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic. Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin. And if that wasn't bad enough, doctors say they have also seen 'life-threatening complications', including seizures, bowel obstruction and inflammation of the pancreas. Model Lottie Moss, 27, even said she had a seizure after taking high doses of Ozempic. The makers of Mounjaro, Lilly UK, said patient safety is its 'top priority'. Lilly UK stressed: 'Regulatory agencies conduct extensive independent assessments of the benefits and risks of every new medicine and Lilly is committed to continually monitoring, evaluating, and reporting safety data. 'If anyone is experiencing side effects when taking any Lilly medicine, they should talk to their doctor or other healthcare professional.' Unlock even more award-winning articles as The Sun launches brand new membership programme - Sun Club